Overview
Implements the 11 diagnostic criteria for Substance Use Disorder as defined in the DSM-5. Provides severity classification: Mild (2–3 criteria), Moderate (4–5), or Severe (6+). This is a screening tool — not a clinical diagnosis.
Clinical Evidence
- The DSM-5 unified previous "Substance Abuse" and "Substance Dependence" categories into a single dimensional SUD diagnosis (APA, 2013).
- The 11-item criteria set was validated across diverse populations with strong internal consistency (Hasin et al., 2013).
- Self-administered screeners show high concordance with clinician-administered assessments for SUD (McNeely et al., 2016).
- Digital screening tools improve detection rates in primary care settings (Tiet et al., 2015).
References
- American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). APA Publishing.
- Hasin, D. S., et al. (2013). DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale. Am. J. Psychiatry, 170(8), 834–851.
- McNeely, J., et al. (2016). Validation of Self-Administered SISQs. J. Gen. Intern. Med., 31(1), 86–93.
Technical Implementation
Pure client-side scoring with zero data transmission for complete privacy. Real-time score calculation with DSM-5 severity threshold mapping.